SWOT Analysis for Ipca Laboratories Ltd.

Add SWOT widget to your site/app

Benjamin Graham Value Screen
Strong Performer, Getting Expensive (DVM)
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Strong Momentum: Price above short, medium and long term moving averages
Rising Net Cash Flow and Cash from Operating activity
Companies with high TTM EPS Growth
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Results Screener: Stocks with upcoming results which are seeing positive shifts in share price
Effectively using its capital to generate profit - RoCE improving in last 2 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Growth in Net Profit with increasing Profit Margin (QoQ)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Increasing profits every quarter for the past 3 quarters
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Companies with Zero Promoter Pledge
Near 52 Week High
RSI indicating price strength
Top Gainers
Stocks near 52 Week High with Significant Volumes

Benjamin Graham Value Screen

Strong Performer, Getting Expensive (DVM)

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Strong Momentum: Price above short, medium and long term moving averages

Rising Net Cash Flow and Cash from Operating activity

Companies with high TTM EPS Growth

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Results Screener: Stocks with upcoming results which are seeing positive shifts in share price

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Increasing profits every quarter for the past 3 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Companies with Zero Promoter Pledge

Near 52 Week High

RSI indicating price strength

Top Gainers

Stocks near 52 Week High with Significant Volumes

Companies with growing costs YoY for long term projects
PE higher than Industry PE
High PE (PE > 40)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Companies with growing costs YoY for long term projects

PE higher than Industry PE

High PE (PE > 40)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Brokers upgraded recommendation or target price in the past three months
Mutual Funds Increased Shareholding in Past Month
FII / FPI or Institutions increasing their shareholding
MFs increased their shareholding last quarter
Mutual Funds Increased Shareholding over the Past Two Months
Mf buying for 2 months

Brokers upgraded recommendation or target price in the past three months

Mutual Funds Increased Shareholding in Past Month

FII / FPI or Institutions increasing their shareholding

MFs increased their shareholding last quarter

Mutual Funds Increased Shareholding over the Past Two Months

Mf buying for 2 months

High Piotroski Score - Companies with strong financials
Indian stocks that could be impacted by Brexit (Britain leaving the EU)
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

High Piotroski Score - Companies with strong financials

Indian stocks that could be impacted by Brexit (Britain leaving the EU)

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Ipca Laboratories Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Ipca Laboratories Ltd. has 23 Strengths, 4 Weaknesses, 6 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Benjamin Graham Value Screen

Strong Performer, Getting Expensive (DVM)

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Strong Momentum: Price above short, medium and long term moving averages

Rising Net Cash Flow and Cash from Operating activity

Companies with high TTM EPS Growth

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Results Screener: Stocks with upcoming results which are seeing positive shifts in share price

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Increasing profits every quarter for the past 3 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Companies with Zero Promoter Pledge

Near 52 Week High

RSI indicating price strength

Top Gainers

Stocks near 52 Week High with Significant Volumes

Companies with growing costs YoY for long term projects

PE higher than Industry PE

High PE (PE > 40)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Brokers upgraded recommendation or target price in the past three months

Mutual Funds Increased Shareholding in Past Month

FII / FPI or Institutions increasing their shareholding

MFs increased their shareholding last quarter

Mutual Funds Increased Shareholding over the Past Two Months

Mf buying for 2 months

High Piotroski Score - Companies with strong financials

Indian stocks that could be impacted by Brexit (Britain leaving the EU)

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks